NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

旅行疫苗市場調查報告:組成,各類型-2025年前的預測-COVID-19累積的影響

Travel Vaccines Market Research Report by Composite, by Type, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

出版商 360iResearch LLP 商品編碼 1002721
出版日期 內容資訊 英文 199 Pages
商品交期: 最快1-2個工作天內
價格
旅行疫苗市場調查報告:組成,各類型-2025年前的預測-COVID-19累積的影響 Travel Vaccines Market Research Report by Composite, by Type, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19
出版日期: 2021年06月01日內容資訊: 英文 199 Pages
簡介

全球旅行疫苗的市場規模預測將從2020年的55億6,663萬美元,擴大到2025年的85億7,999萬美元。

COVID-19是前所未有的全球性公共衛生突發事件,已影響到每個行業。這種長期影響預計將在預測期內影響行業增長。我們正在進行的研究正在擴大我們的研究範圍,以確保我們窮究潛在的COVID-19問題和未來路徑。該報告考慮了消費者行為和需求的變化,購買方式,供應鏈的重新改道,當前市場趨勢以及政府的重要介入等因素,提供有關COVID-19的洞察。

本報告提供旅行疫苗市場相關調查,提供市場概要,以及組成,各類型,各地區的趨勢,COVID-19累積的影響,及加入此市場的主要企業簡介等資訊。

目錄

第1章 序文

  • 調查的目的
  • 市場區隔和範圍
  • 調查對象年
  • 貨幣和價格
  • 語言
  • 限制事項
  • 利害關係者

第2章 調查手法

  • 調查流程
    • 定義:調查目的
    • 決策:調查設計
    • 準備:調查設備
    • 收集:資料來源
    • 分析:資料的解釋
    • 制定:資料檢驗
    • 公開:調查報告
    • 重複:報告的更新
  • 調查的實行
    • 開始:調查流程
    • 計劃:調查計劃作成
    • 實行:調查實施
    • 檢驗:發現與分析
    • 出版物:調查報告
  • 調查成果

第3章 摘要整理

  • 簡介
  • 市場預測
  • 各組成預測
  • 各類型預測
  • 各地區預測
  • 其他競爭公司預測

第4章 市場概要

  • 簡介
  • COVID-19累積的影響

第5章 市場洞察

  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機會
    • 課題
  • 波特五力分析
    • 新加入廠商業者的威脅
    • 替代品的威脅
    • 客戶談判力
    • 供給企業談判力
    • 產業的競爭

第6章 全球旅行疫苗市場,各組成

  • 混合疫苗
  • 東西疫苗

第7章 全球旅行疫苗市場,各類型

  • 弱毒化疫苗
  • 結合型疫苗
  • DNA疫苗
  • 不活化疫苗
  • 重組載體疫苗
  • 次單元疫苗
  • 類毒素疫苗

第8章 南北美洲的旅行疫苗市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章 亞太地區的旅行疫苗市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 韓國
  • 泰國

第10章 歐洲,中東·非洲的旅行疫苗市場

  • 法國
  • 德國
  • 義大利
  • 荷蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 阿拉伯聯合大公國
  • 英國

第11章 競爭情形

  • FPNV定位矩陣
    • 象限
    • 事業策略
    • 產品的滿意度
  • 市場排行榜分析
  • 市場佔有率分析
  • 其他競爭公司的SWOT分析
  • 競爭模式
    • 合併和收購
    • 契約,合作,及夥伴關係
    • 新產品的銷售與強化
    • 投資與資金籌措
    • 獎,獎勵,擴大

第12章 企業的實用性簡介

  • Abbott Laboratories
  • ALK-Abello A/S
  • Altimmune, Inc
  • AstraZeneca PLC
  • Bausch Health Companies Inc.
  • Bavarian Nordic A/S
  • Baxter International Inc
  • Cadila Healthcare Limited
  • CSL Limited
  • Dynavax Technologies
  • Emergent BioSolutions Inc.
  • F. Hoffmann-La Roche AG
  • GlaxoSmithKline PLC
  • Hualan Biological Engineering Inc.
  • Janssen Vaccines (Subsidiary of Johnson & Johnson)
  • Medimmune LLC
  • Merck & Co., Inc.
  • Novartis International AG
  • Pfizer Inc.
  • Sanofi S.A
  • Serum Institute of India
  • Shenzhen Kangtai biological products Limited
  • SK Chemicals
  • Takeda Pharmaceuticals U.S.A., Inc.
  • Valneva SE

第13章 附錄

  • 討論指南
  • 許可證和價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MRR-0316851957A4

The Global Travel Vaccines Market size was estimated at USD 5,566.63 Million in 2020 and expected to reach USD 6,097.58 Million in 2021, at a Compound Annual Growth Rate (CAGR) 9.87% to reach USD 9,795.46 Million by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Travel Vaccines to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Composite, the Travel Vaccines Market was studied across Combination Vaccines and Mono Vaccine.

Based on Type, the Travel Vaccines Market was studied across Attenuated Vaccines, Conjugate Vaccines, DNA Vaccines, Inactive Vaccines, Recombinant Vector Vaccines, Subunit Vaccines, and Toxoid Vaccines.

Based on Geography, the Travel Vaccines Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Travel Vaccines Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Travel Vaccines Market, including Abbott Laboratories, ALK-Abello A/S, Altimmune, Inc, AstraZeneca PLC, Bausch Health Companies Inc., Bavarian Nordic A/S, Baxter International Inc, Cadila Healthcare Limited, CSL Limited, Dynavax Technologies, Emergent BioSolutions Inc., F. Hoffmann-La Roche AG, GlaxoSmithKline PLC, Hualan Biological Engineering Inc., Janssen Vaccines (Subsidiary of Johnson & Johnson), Medimmune LLC, Merck & Co., Inc., Novartis International AG, Pfizer Inc., Sanofi S.A, Serum Institute of India, Shenzhen Kangtai biological products Limited, SK Chemicals, Takeda Pharmaceuticals U.S.A., Inc., and Valneva SE.

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Travel Vaccines Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Travel Vaccines Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Travel Vaccines Market?
  • 4. What is the competitive strategic window for opportunities in the Global Travel Vaccines Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Travel Vaccines Market?
  • 6. What is the market share of the leading vendors in the Global Travel Vaccines Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global Travel Vaccines Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

  • 3.1. Introduction
  • 3.2. Market Outlook
  • 3.3. Composite Outlook
  • 3.4. Type Outlook
  • 3.5. Geography Outlook
  • 3.6. Competitor Outlook

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing number of international tourism
      • 5.1.1.2. Rising research & development activities by key players
      • 5.1.1.3. Growing development of combination vaccines
    • 5.1.2. Restraints
      • 5.1.2.1. Higher expenditure in research & development
    • 5.1.3. Opportunities
      • 5.1.3.1. Innovations in novel vaccine technologies and tech advancements
      • 5.1.3.2. Government support for development of vaccines
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of awareness amongst travellers
  • 5.2. Cumulative Impact of COVID-19
  • 5.3. Porters Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry

6. Travel Vaccines Market, by Composite

  • 6.1. Introduction
  • 6.2. Combination Vaccines
  • 6.3. Mono Vaccine

7. Travel Vaccines Market, by Type

  • 7.1. Introduction
  • 7.2. Attenuated Vaccines
  • 7.3. Conjugate Vaccines
  • 7.4. DNA Vaccines
  • 7.5. Inactive Vaccines
  • 7.6. Recombinant Vector Vaccines
  • 7.7. Subunit Vaccines
  • 7.8. Toxoid Vaccines

8. Americas Travel Vaccines Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States
    • 8.6.1. California
    • 8.6.2. Florida
    • 8.6.3. Illinois
    • 8.6.4. New York
    • 8.6.5. Ohio
    • 8.6.6. Pennsylvania
    • 8.6.7. Texas

9. Asia-Pacific Travel Vaccines Market

  • 9.1. Introduction
  • 9.2. China
  • 9.3. India
  • 9.4. Indonesia
  • 9.5. Japan
  • 9.6. Malaysia
  • 9.7. Philippines
  • 9.8. South Korea
  • 9.9. Thailand

10. Europe, Middle East & Africa Travel Vaccines Market

  • 10.1. Introduction
  • 10.2. France
  • 10.3. Germany
  • 10.4. Italy
  • 10.5. Netherlands
  • 10.6. Qatar
  • 10.7. Russia
  • 10.8. Saudi Arabia
  • 10.9. South Africa
  • 10.10. Spain
  • 10.11. United Arab Emirates
  • 10.12. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
    • 11.1.1. Quadrants
    • 11.1.2. Business Strategy
    • 11.1.3. Product Satisfaction
  • 11.2. Market Ranking Analysis
  • 11.3. Market Share Analysis, By Quadrant
  • 11.4. Market Share Analysis, By Company
  • 11.5. Competitive Scenario
    • 11.5.1. Merger & Acquisition
    • 11.5.2. Agreement, Collaboration, & Partnership
    • 11.5.3. New Product Launch & Enhancement
    • 11.5.4. Investment & Funding
    • 11.5.5. Award, Recognition, & Expansion

12. Company Usability Profiles

  • 12.1. Abbott Laboratories
  • 12.2. ALK-Abello A/S
  • 12.3. Altimmune, Inc
  • 12.4. AstraZeneca PLC
  • 12.5. Bausch Health Companies Inc.
  • 12.6. Bavarian Nordic A/S
  • 12.7. Baxter International Inc
  • 12.8. Cadila Healthcare Limited
  • 12.9. CSL Limited
  • 12.10. Dynavax Technologies
  • 12.11. Emergent BioSolutions Inc.
  • 12.12. F. Hoffmann-La Roche AG
  • 12.13. GlaxoSmithKline PLC
  • 12.14. Hualan Biological Engineering Inc.
  • 12.15. Janssen Vaccines (Subsidiary of Johnson & Johnson)
  • 12.16. Medimmune LLC
  • 12.17. Merck & Co., Inc.
  • 12.18. Novartis International AG
  • 12.19. Pfizer Inc.
  • 12.20. Sanofi S.A
  • 12.21. Serum Institute of India
  • 12.22. Shenzhen Kangtai biological products Limited
  • 12.23. SK Chemicals
  • 12.24. Takeda Pharmaceuticals U.S.A., Inc.
  • 12.25. Valneva SE

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing
  • 13.3. Contact Details

LIST OF FIGURES

  • FIGURE 1. GLOBAL TRAVEL VACCINES MARKET SIZE, 2020 VS 2026 (USD MILLION)
  • FIGURE 2. GLOBAL TRAVEL VACCINES MARKET SIZE, BY COMPOSITE, 2020 (USD MILLION)
  • FIGURE 3. GLOBAL TRAVEL VACCINES MARKET SIZE, BY TYPE, 2020 (USD MILLION)
  • FIGURE 4. GLOBAL TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
  • FIGURE 5. GLOBAL TRAVEL VACCINES MARKET: MARKET DYNAMICS
  • FIGURE 6. GLOBAL TRAVEL VACCINES MARKET: PORTERS FIVE FORCES ANALYSIS
  • FIGURE 7. GLOBAL TRAVEL VACCINES MARKET SIZE, BY COMPOSITE, 2020 VS 2026 (%)
  • FIGURE 8. GLOBAL TRAVEL VACCINES MARKET SIZE, BY COMPOSITE, 2020 VS 2026 (USD MILLION)
  • FIGURE 9. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL TRAVEL VACCINES MARKET SIZE, BY COMPOSITE, 2026
  • FIGURE 10. GLOBAL TRAVEL VACCINES MARKET SIZE, BY COMBINATION VACCINES, 2018-2026 (USD MILLION)
  • FIGURE 11. GLOBAL TRAVEL VACCINES MARKET SIZE, BY COMBINATION VACCINES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 12. GLOBAL TRAVEL VACCINES MARKET SIZE, BY MONO VACCINE, 2018-2026 (USD MILLION)
  • FIGURE 13. GLOBAL TRAVEL VACCINES MARKET SIZE, BY MONO VACCINE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 14. GLOBAL TRAVEL VACCINES MARKET SIZE, BY TYPE, 2020 VS 2026 (%)
  • FIGURE 15. GLOBAL TRAVEL VACCINES MARKET SIZE, BY TYPE, 2020 VS 2026 (USD MILLION)
  • FIGURE 16. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL TRAVEL VACCINES MARKET SIZE, BY TYPE, 2026
  • FIGURE 17. GLOBAL TRAVEL VACCINES MARKET SIZE, BY ATTENUATED VACCINES, 2018-2026 (USD MILLION)
  • FIGURE 18. GLOBAL TRAVEL VACCINES MARKET SIZE, BY ATTENUATED VACCINES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 19. GLOBAL TRAVEL VACCINES MARKET SIZE, BY CONJUGATE VACCINES, 2018-2026 (USD MILLION)
  • FIGURE 20. GLOBAL TRAVEL VACCINES MARKET SIZE, BY CONJUGATE VACCINES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 21. GLOBAL TRAVEL VACCINES MARKET SIZE, BY DNA VACCINES, 2018-2026 (USD MILLION)
  • FIGURE 22. GLOBAL TRAVEL VACCINES MARKET SIZE, BY DNA VACCINES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 23. GLOBAL TRAVEL VACCINES MARKET SIZE, BY INACTIVE VACCINES, 2018-2026 (USD MILLION)
  • FIGURE 24. GLOBAL TRAVEL VACCINES MARKET SIZE, BY INACTIVE VACCINES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 25. GLOBAL TRAVEL VACCINES MARKET SIZE, BY RECOMBINANT VECTOR VACCINES, 2018-2026 (USD MILLION)
  • FIGURE 26. GLOBAL TRAVEL VACCINES MARKET SIZE, BY RECOMBINANT VECTOR VACCINES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 27. GLOBAL TRAVEL VACCINES MARKET SIZE, BY SUBUNIT VACCINES, 2018-2026 (USD MILLION)
  • FIGURE 28. GLOBAL TRAVEL VACCINES MARKET SIZE, BY SUBUNIT VACCINES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 29. GLOBAL TRAVEL VACCINES MARKET SIZE, BY TOXOID VACCINES, 2018-2026 (USD MILLION)
  • FIGURE 30. GLOBAL TRAVEL VACCINES MARKET SIZE, BY TOXOID VACCINES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 31. AMERICAS TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 32. AMERICAS TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 33. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 34. ARGENTINA TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 35. BRAZIL TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 36. CANADA TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 37. MEXICO TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 38. UNITED STATES TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 39. CALIFORNIA TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 40. FLORIDA TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 41. ILLINOIS TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 42. NEW YORK TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 43. OHIO TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 44. PENNSYLVANIA TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 45. TEXAS TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 46. ASIA-PACIFIC TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 47. ASIA-PACIFIC TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 48. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 49. CHINA TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 50. INDIA TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 51. INDONESIA TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 52. JAPAN TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 53. MALAYSIA TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 54. PHILIPPINES TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 55. SOUTH KOREA TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 56. THAILAND TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 57. EUROPE, MIDDLE EAST & AFRICA TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 58. EUROPE, MIDDLE EAST & AFRICA TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 59. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 60. FRANCE TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 61. GERMANY TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 62. ITALY TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 63. NETHERLANDS TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 64. QATAR TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 65. RUSSIA TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 66. SAUDI ARABIA TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 67. SOUTH AFRICA TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 68. SPAIN TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 69. UNITED ARAB EMIRATES TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 70. UNITED KINGDOM TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 71. GLOBAL TRAVEL VACCINES MARKET: FPNV POSITIONING MATRIX
  • FIGURE 72. GLOBAL TRAVEL VACCINES MARKET: SHARE, BY QUADRANT, 2020
  • FIGURE 73. GLOBAL TRAVEL VACCINES MARKET: SHARE, BY COMPANY, 2020
  • FIGURE 74. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL TRAVEL VACCINES MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL TRAVEL VACCINES MARKET: MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL TRAVEL VACCINES MARKET SIZE, BY COMPOSITE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 4. GLOBAL TRAVEL VACCINES MARKET SIZE, BY COMBINATION VACCINES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 5. GLOBAL TRAVEL VACCINES MARKET SIZE, BY MONO VACCINE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 6. GLOBAL TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 7. GLOBAL TRAVEL VACCINES MARKET SIZE, BY ATTENUATED VACCINES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 8. GLOBAL TRAVEL VACCINES MARKET SIZE, BY CONJUGATE VACCINES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 9. GLOBAL TRAVEL VACCINES MARKET SIZE, BY DNA VACCINES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 10. GLOBAL TRAVEL VACCINES MARKET SIZE, BY INACTIVE VACCINES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 11. GLOBAL TRAVEL VACCINES MARKET SIZE, BY RECOMBINANT VECTOR VACCINES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 12. GLOBAL TRAVEL VACCINES MARKET SIZE, BY SUBUNIT VACCINES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 13. GLOBAL TRAVEL VACCINES MARKET SIZE, BY TOXOID VACCINES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 14. AMERICAS TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 15. AMERICAS TRAVEL VACCINES MARKET SIZE, BY COMPOSITE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 16. AMERICAS TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 17. ARGENTINA TRAVEL VACCINES MARKET SIZE, BY COMPOSITE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 18. ARGENTINA TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 19. BRAZIL TRAVEL VACCINES MARKET SIZE, BY COMPOSITE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 20. BRAZIL TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 21. CANADA TRAVEL VACCINES MARKET SIZE, BY COMPOSITE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 22. CANADA TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 23. MEXICO TRAVEL VACCINES MARKET SIZE, BY COMPOSITE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 24. MEXICO TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 25. UNITED STATES TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 26. UNITED STATES TRAVEL VACCINES MARKET SIZE, BY COMPOSITE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 27. UNITED STATES TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 28. CALIFORNIA TRAVEL VACCINES MARKET SIZE, BY COMPOSITE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 29. CALIFORNIA TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 30. FLORIDA TRAVEL VACCINES MARKET SIZE, BY COMPOSITE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 31. FLORIDA TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 32. ILLINOIS TRAVEL VACCINES MARKET SIZE, BY COMPOSITE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 33. ILLINOIS TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 34. NEW YORK TRAVEL VACCINES MARKET SIZE, BY COMPOSITE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 35. NEW YORK TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 36. OHIO TRAVEL VACCINES MARKET SIZE, BY COMPOSITE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 37. OHIO TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 38. PENNSYLVANIA TRAVEL VACCINES MARKET SIZE, BY COMPOSITE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 39. PENNSYLVANIA TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 40. TEXAS TRAVEL VACCINES MARKET SIZE, BY COMPOSITE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 41. TEXAS TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 42. ASIA-PACIFIC TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 43. ASIA-PACIFIC TRAVEL VACCINES MARKET SIZE, BY COMPOSITE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 44. ASIA-PACIFIC TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 45. CHINA TRAVEL VACCINES MARKET SIZE, BY COMPOSITE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 46. CHINA TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 47. INDIA TRAVEL VACCINES MARKET SIZE, BY COMPOSITE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 48. INDIA TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 49. INDONESIA TRAVEL VACCINES MARKET SIZE, BY COMPOSITE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 50. INDONESIA TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 51. JAPAN TRAVEL VACCINES MARKET SIZE, BY COMPOSITE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 52. JAPAN TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 53. MALAYSIA TRAVEL VACCINES MARKET SIZE, BY COMPOSITE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 54. MALAYSIA TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 55. PHILIPPINES TRAVEL VACCINES MARKET SIZE, BY COMPOSITE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 56. PHILIPPINES TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 57. SOUTH KOREA TRAVEL VACCINES MARKET SIZE, BY COMPOSITE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 58. SOUTH KOREA TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 59. THAILAND TRAVEL VACCINES MARKET SIZE, BY COMPOSITE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 60. THAILAND TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 61. EUROPE, MIDDLE EAST & AFRICA TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 62. EUROPE, MIDDLE EAST & AFRICA TRAVEL VACCINES MARKET SIZE, BY COMPOSITE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 63. EUROPE, MIDDLE EAST & AFRICA TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 64. FRANCE TRAVEL VACCINES MARKET SIZE, BY COMPOSITE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 65. FRANCE TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 66. GERMANY TRAVEL VACCINES MARKET SIZE, BY COMPOSITE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 67. GERMANY TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 68. ITALY TRAVEL VACCINES MARKET SIZE, BY COMPOSITE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 69. ITALY TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 70. NETHERLANDS TRAVEL VACCINES MARKET SIZE, BY COMPOSITE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 71. NETHERLANDS TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 72. QATAR TRAVEL VACCINES MARKET SIZE, BY COMPOSITE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 73. QATAR TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 74. RUSSIA TRAVEL VACCINES MARKET SIZE, BY COMPOSITE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 75. RUSSIA TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 76. SAUDI ARABIA TRAVEL VACCINES MARKET SIZE, BY COMPOSITE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 77. SAUDI ARABIA TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 78. SOUTH AFRICA TRAVEL VACCINES MARKET SIZE, BY COMPOSITE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 79. SOUTH AFRICA TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 80. SPAIN TRAVEL VACCINES MARKET SIZE, BY COMPOSITE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 81. SPAIN TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 82. UNITED ARAB EMIRATES TRAVEL VACCINES MARKET SIZE, BY COMPOSITE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 83. UNITED ARAB EMIRATES TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 84. UNITED KINGDOM TRAVEL VACCINES MARKET SIZE, BY COMPOSITE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 85. UNITED KINGDOM TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 86. GLOBAL TRAVEL VACCINES MARKET: SCORES
  • TABLE 87. GLOBAL TRAVEL VACCINES MARKET: BUSINESS STRATEGY
  • TABLE 88. GLOBAL TRAVEL VACCINES MARKET: PRODUCT SATISFACTION
  • TABLE 89. GLOBAL TRAVEL VACCINES MARKET: RANKING
  • TABLE 90. GLOBAL TRAVEL VACCINES MARKET: SHARE, BY QUADRANT, 2020
  • TABLE 91. GLOBAL TRAVEL VACCINES MARKET: SHARE, BY COMPANY, 2020
  • TABLE 92. GLOBAL TRAVEL VACCINES MARKET: MERGER & ACQUISITION
  • TABLE 93. GLOBAL TRAVEL VACCINES MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 94. GLOBAL TRAVEL VACCINES MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 95. GLOBAL TRAVEL VACCINES MARKET: INVESTMENT & FUNDING
  • TABLE 96. GLOBAL TRAVEL VACCINES MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 97. GLOBAL TRAVEL VACCINES MARKET: LICENSE & PRICING
  • TABLE 98. GLOBAL TRAVEL VACCINES MARKET: CONTACT DETAILS